Overview A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors Status: Recruiting Trial end date: 2023-12-31 Target enrollment: Participant gender: Summary This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors Phase: Phase 1 Details Lead Sponsor: Betta Pharmaceuticals Co., Ltd.